Research ArticleArticle
Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor
Rhonda L. Carter, Ingrid P. Fricks, Matthew O. Barrett, Lauren E. Burianek, Yixing Zhou, Hyojin Ko, Arijit Das, Kenneth A. Jacobson, Eduardo R. Lazarowski and T. Kendall Harden
Molecular Pharmacology December 2009, 76 (6) 1341-1348; DOI: https://doi.org/10.1124/mol.109.058578
Rhonda L. Carter
Ingrid P. Fricks
Matthew O. Barrett
Lauren E. Burianek
Yixing Zhou
Hyojin Ko
Arijit Das
Kenneth A. Jacobson
Eduardo R. Lazarowski
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor
Rhonda L. Carter, Ingrid P. Fricks, Matthew O. Barrett, Lauren E. Burianek, Yixing Zhou, Hyojin Ko, Arijit Das, Kenneth A. Jacobson, Eduardo R. Lazarowski and T. Kendall Harden
Molecular Pharmacology December 1, 2009, 76 (6) 1341-1348; DOI: https://doi.org/10.1124/mol.109.058578
Research ArticleArticle
Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor
Rhonda L. Carter, Ingrid P. Fricks, Matthew O. Barrett, Lauren E. Burianek, Yixing Zhou, Hyojin Ko, Arijit Das, Kenneth A. Jacobson, Eduardo R. Lazarowski and T. Kendall Harden
Molecular Pharmacology December 1, 2009, 76 (6) 1341-1348; DOI: https://doi.org/10.1124/mol.109.058578
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement